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Pathogenesis of atherosclerosis and neointima formation after angioplasty involves vascular smooth muscle cells (VSMCs)
migration and proliferation followed by inflammatory responses mediated by recruited macrophages in the neointima. Terminalia
chebula is widely used traditionalmedicine inAsia for its beneficial effects against cancer, diabetes, and bacterial infection.The study
was designed to determine whether Terminalia chebula fructus water extract (TFW) suppresses VSMCmigration and proliferation
and inflammatorymediators production inmacrophage (RAW264.7). Our results showed that TFWpossessed strong antioxidative
effects in 1,1-diphenyl-2-picryl hydrazyl (DPPH) scavenging and lipid peroxidation assays. In addition, TFW reduced nitric oxide
(NO) production, inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) expression in RAW 264.7 cells. Also,
TFW inhibited platelet-derived growth factor (PDGF-BB) induced VSMCmigration as determined by wound healing and Boyden
chamber assays.The antimigratory effect of TFWwas due to its inhibitory effect onmetalloproteinase-9 (MMP-9) expression, focal
adhesion kinase (FAK) activation, and Rho-family of small GTPases (Cdc42 and RhoA) expression in VSMCs. Furthermore, TFW
suppressed PDGF-BB induced VSMC proliferation by downregulation of mitogen activated protein kinases (MAPKs) signaling
molecules. These results suggest that TFW could be a beneficial resource in the prevention of atherosclerosis.
1. Introduction
Pathogenesis of atherosclerosis and neointima formation
after angioplasty can be described as the complex involve-
ment of several growth factors including platelet-derived
growth factor (PDGF-BB) and tumor necrosis factor alpha
(TNF-𝛼) that induce vascular smooth muscle cells (VSMCs)
migration and proliferation [1, 2]. During the early stages of
atherosclerosis or arterial wall injury, VSMCs may undergo
transition from a contractile to a synthetic phenotype and
begin proliferation in response to PDGF-BB, a potent growth
factor and chemoattractant produced by vascular endothelial
cells, platelets, VSMCs, and macrophages [3]. PDGF-BB and
TNF-𝛼 have been reported to promote cell proliferation
through mitogen activated protein kinases (MAPKs) and
nuclear factor kappa B (NF-𝜅B) activation pathways [4]. The
accumulation of VSMCs within the intima is the result of
VSMCmigration frommedia to intima in response to PDGF-
BB [5]. VSMCmigration frommedia to intima involves enzy-
matic action of matrix metalloproteinases (MMPs), specifi-
cally MMP-2 and MMP-9, that degrade extracellular matrix
(ECM) thereby facilitating VSMCmigration [6]. In addition,
cytoskeleton remodeling, which is associated with focal
adhesion kinase (FAK) phosphorylation and small GTPases
activation, is required to generate the driving force for VSMC
migration [7–9].Therefore, inhibition of the molecular path-
ways responsible for VSMC proliferation and migration is a
widely used strategy in the development of the drugs against
atherosclerosis and restenosis.
Atherosclerotic progression follows inflammatory re-
sponses mediated by macrophages. The circulating mono-
cytes are recruited and differentiated into macrophages in
response to monocyte chemoattractant protein (MCP-1) [10].
Activation of these macrophages results in inducible nitric
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oxide synthase (iNOS) and cyclooxygenase (COX-2) synthe-
sis [11]. Studies have shown proatherosclerotic role of iNOS
that is caused by the massive production of nitric oxide (NO)
and subsequent formation of peroxynitrite [12], a powerful
oxidant, and can lead to oxidation of low density lipoproteins
(LDL) [13]. Macrophages engulf oxidized LDL and turn into
foam cells [14]. Prostaglandins produced by the action of
COX-2 have been shown to be mitogenic, leading to cellular
proliferation [15].
Most people in developing countries depend on comple-
mentary and alternative therapies, especially those derived
from botanical origins. They use plants as a source of medi-
cine for their primary health needs, because plants are consid-
ered less toxic, with fewer adverse effects than synthetic drugs
[16]. Therefore, interest in natural remedies and therapeutic
use of natural products for the prevention of atherosclerosis
and associated inflammation has been growing. Terminalia
chebula, which is naturally distributed to South East Asia, is
one of the promising traditional medicines. Application of T.
chebula has been widely accredited in Ayurveda [17]. Various
forms of T. chebula extracts have been frequently applied
as traditional medicines for their laxative, astringent, purga-
tive, diuretic, antioxidant, antimicrobial, antidiabetic, and
antimutagenic activity [18]. T. chebula has been considered
to promote health, immunity, and longevity [19]. However, to
the best of our knowledge, no one has reported the beneficial
effects of T. chebula in atherosclerosis and associated inflam-
mation. Therefore, the aim of this study was to deter-
mine whether T. chebula possessed antiatherosclerotic action
through modulating VSMC proliferation and migration and
attenuates inflammatory responses mediated by RAW 264.7.
2. Materials and Methods
2.1. Reagents. MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-di-
phenyl tetrazolium bromide), antibody to 𝛽-actin, and lipo-
polysaccharide (LPS) were purchased from Sigma (St Louis,
MO, USA). The antibodies to phosphorylated ERK (pERK1/
2), ERK1/2, pJNK, JNK, pFAK, and FAKwere purchased from
Cell Signaling Technology (Beverly, MA, USA), antibodies
to RhoA, Cdc42, and GAPDH were purchased from Santa
Cruz (Santa Cruz, CA, USA), and antibody to MMP-9
was obtained from Millipore (Billerica, MA, USA). Platelet-
derived growth factor (PDGF-BB) and tumor necrosis
factor alpha (TNF-𝛼) were obtained from R & D systems
(Minneapolis, USA). Nitrocellulose membrane and chemilu-
minescent for Western blotting were purchased from Bio-
Rad (Richmond, CA, USA) and IMEGENEX (San Diego,
CA, USA), respectively. All solvents, chemicals, and reagents
were of analytical grade and purchased from Sigma-Aldrich
unless otherwise specified.
2.2. Plant Material. Dried fruits from T. chebula, purchased
fromMuan province of Korea, were extracted with hot water
for 3 times using soxhlet extractor. The extract was then
filtered and evaporated under vacuum followed by lyophiliza-
tion. The lyophilized powder (TFW) was resuspended in
distilled water and filtered by a 0.22𝜇m for use in cell
culture. The yield of the extract was about 9% of the starting
material. Total phenolic acid content in TFW was measured
as described previously [20]. The polysaccharide and protein
contents in TFWwere assessed using the phenol-sulfuric acid
method and Bio-Rad protein assay kit (Hercules, CA, USA),
respectively.The tannin content was determined by Folin and
Ciocalteu method and expressed as mg gallic acid equivalent
(mg gallic acid/g extract) [21].
2.3. Cell Culture. VSMCs, purchased from Bio-Whittaker
(San Diego, CA, USA), and RAW 264.7 cells, purchased from
Korean Cell Bank (Seoul, Korea), were cultured Dulbecco’s
modified Eagel’s medium (DMEM) supplemented with 10%
heat-inactivated fetal bovine serum (FBS), 100 unit/mL
penicillin, and 100 𝜇g streptomycin at 37∘C in a humidified
atmosphere containing 5% CO
2
. VSMCs were incubated in
DMEM supplemented with 0.1% FBS for 24 h to synchronize
them at G0 phase.
2.4. DPPH Scavenging Activity, Metal-Chelating Activity, and
Lipid Peroxidation. DPPH scavenging activity and metal-
chelating activity of TFW were measured as described pre-
viously [22, 23]. Effect of TFW on serum lipid peroxidation
was determined by TBARS assay as described previously [22].
2.5. NO Production, iNOS, and COX-2 Expression in RAW
264.7 Cells. Effects of TFW on NO production, iNOS, and
COX-2 expression in RAW 264.7 cells were determined as
described previously [23]. Briefly, the cells were pretreated
with TFW for 1 h followed by stimulation with 1𝜇g/mL of
lipopolysaccharide (LPS) for 24 h. Griess reagent was used to
measureNO level in the supernatant.The absorbance of chro-
mophore was measured at 540 nm. Similarly, LPS induced
iNOS and COX-2 expression in RAW 264.7 cells were deter-
mined by Western blot.
2.6. Wound Healing Assay. The monolayer of confluent
VSMCs was scratched with a yellow tip to create a migrating
zone, followed by washing with phosphate buffered saline
(PBS) to remove debris. TFW at different concentrations was
pretreated for 1 h prior to stimulation of the cells with PDGF-
BB (20 ng/mL) for 24 h. The distance of migrating zone was
photographed in 0, 12, and 24 h by light microscope under a
magnification of 100x [8].
2.7. Boyden’s Chamber Assay. VSMC migration was per-
formed with a modified Boyden’s chamber assay. The lower
face of polycarbonate membrane (Sigma Aldrich, USA) was
coated with 2.5% gelatin in 1M acetic acid. The cells were
seeded at a density of 1 × 105 cells/mL in 200𝜇L of DMEM
containing 0.1% bovine serum albumin (BSA) in the upper
chamber, which was then immersed in lower chamber con-
taining 600𝜇L of DMEM with PDGF-BB (20 ng/mL) and
TFW. The cells were allowed to migrate for 6 h. Afterwards,
cells remaining on the inner membrane of the chamber were
removed by cotton swabs. Migrated cells were fixed in 10%
formalin and stained with hematoxylin and eosin.The mem-
branes were washed and mounted on slides. The migrating
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cells were photographed by light microscope at the magnifi-
cation of 200x [8].
2.8. Gelatin Zymography. VSMCs were pretreated with TFW
for 1 h prior to stimulation with TNF-𝛼 (100 ng/mL) for 24 h.
The enzymatic action of MMP-2 and MMP-9 in supernatant
and cell lysate was determined by gelatin zymography as
described previously [8]. Briefly, gels obtained after elec-
trophoresis were washed in 2.5% Triton X-100 for 30min
and incubated at 37∘C for 24 h in developing buffer. The gels
were subsequently stained with coomassie brilliant blue and
destained with destaining buffer. The zymograms were pho-
tographed. Proteolytic activity was detected as a white zone
in the blue background.
2.9. Proliferation Assay. VSMC proliferation was assessed by
usingMTT assay as described previously [24]. VSMCs seeded
in 96-well plates were pretreated with TFW for 1 h prior to
stimulation of the cells with PDGF-BB (20 ng/mL) for addi-
tional 24 h. Then, MTT solution was added for 4 h followed
by solubilization of formazan crystals in dimethyl sulfoxide
(DMSO). The purple color thus formed was measured at
540 nm.
2.10. Western Blot Analysis. The protein expression of iNOS
and COX-2 in RAW 264.7, activation of ERK, JNK, and
FAK, and protein expression of MMP-9, RhoA, and Cdc42
in VSMCs were determined by Western blot analysis as
described previously [24].
2.11. Statistical Analysis. SPSS (SPSS, Chicago, IL, USA) was
used to perform statistical data analysis. All data were pre-
sented as mean ± standard deviation. Groups were compared
by using one-way analysis of variance (ANOVA) followed by
Duncan’s post hoc test of multiple comparisons. 𝑃 values ≤
0.05 were considered statistically significant.
3. Results
3.1. Components of TFW. Dried fruits of T. chebula, obtained
from Muan Province, Korea, were extracted with water as
described underMaterials andMethods to produce TFWdry
powder. Total phenolic acid and total tannin content were
found to be approximately 28.7% and 31.6%, respectively.The
protein and polysaccharide contents of TFW were approxi-
mately 4.1%, and 9.1%, respectively. Because TFW contains
abundant tannins, we assume that these tannins may be the
main components responsible for the pharmacological effects
of TFW.
3.2. TFW Scavenges Oxidation and Possesses Metal-Chelating
Activity. Dose-response curve of DPPH scavenging activity
of TFW, gallic acid, and chebulic acid is shown in Figure 1(a).
Inhibitory concentration 50 (IC
50
) values of TFW, gallic acid,
and chebulic acid were found to be 1.52, 0.85, and 1.1 𝜇g/mL,
respectively. Figure 1(b) shows the dose-response curve of
metal-chelating activity of TFW and gallic acid. IC
50
values
of TFW, gallic acid, and chebulic acid for metal-chelating
activity were 712.1, 33.4, and 75.4𝜇g/mL, respectively. Nev-
ertheless, when compared to EDTA (1𝜇g/mL), the chelating
activity of TFW or gallic acid or chebulic acid was found to
be low. Furthermore, the concentration of malondialdehyde
(MDA), ameasure of serum lipid peroxidation, in the normal
and the control groups was 1.2 ± 0.4 and 13 ± 0.7 𝜇M,
respectively. TFW, gallic acid, and chebulic acid significantly
reduced serum lipid peroxidation induced by CuSO
4
in a
dose dependent manner (Figure 1(c)).
3.3. TFW Inhibits iNOS, COX-2 Expression, and NO Pro-
duction in RAW 264.7 Cells. The anti-inflammatory effect of
TFW was determined in lipopolysaccharide (LPS) induced
RAW 264.7 cells. TFW up to 250𝜇g/mL did not show any
toxicity in normal cells (Figure 2(a)). Stimulation of the cells
with LPS for 24 h increased the production of NO (56.6 ±
2.6 𝜇M). TWF dose dependently decreased LPS induced
NO production (Figure 2(b)). Similarly, the expression of
inflammatory enzymes COX-2 and iNOS were induced by
LPS. TWF significantly decreased the expression of both
iNOS and COX-2 (Figures 2(c)–2(e)).
3.4. TFW Inhibits VSMC Migration. The effects of TFW on
VSMCmigration as evaluated by using awound healing assay
and Boyden chamber are as shown in Figure 3. TFW dose
dependently suppressed PDGF-BB induced VSMC wound
healing for 6, 12, and 24 h after injury (Figure 3(b)). TFW
at 100 and 250𝜇g/mL showed the significant inhibition of
healing (approximately 30% and 56% compared with control,
resp.) at 12 h. The magnitude of inhibition remained sup-
pressed with 50, 100, and 250𝜇g/mL of TFW (approxi-
mately 20%, 35%, and 60% compared with control, resp.) at
24 h. Next, we evaluated VSMC migration using a modified
transwell apparatus. The cellular migration was induced by
PDGF-BB that increased the basal migration of VSMC by
4.4-fold compared to PDGF-BB nontreated cells. TFW at 50,
100, and 250𝜇g/mL inhibited PDGF-BB-stimulated VSMC
migration by 45%, 74%, and 75%, respectively (Figure 3(d)).
3.5. TFW Inhibits MMPs Expression and FAK Activation to
Attenuate VSMC Migration. VSMC migration involves both
degradation of ECM by MMPs and cytoskeletal remodeling,
which is regulated by various growth factors and cytokines
[8]. MMP-2 and MMP-9 have been reported to degrade
ECM thereby facilitating VSMC migration. We used TNF-
𝛼 to induce MMP-9 expression. As shown in Figure 4(a),
stimulation of VSMCs with TNF-𝛼 for 24 h enhanced the
proteolytic activity and protein expression of MMP-9 while
MMP-2 was constitutively secreted. The pretreatment of
TFW strongly inhibited MMP-9 proteolytic activity and
protein expression (Figures 4(a)-4(b)). Upon cells adhesion
to ECM, FAK becomes activated through tyrosine phospho-
rylation, notably at Tyr397 [25]. We next examined if TFW
affected PDGF-BB-induced FAK phosphorylation. As shown
in Figures 4(c)-4(d), TFW inhibited PDGF-BB-induced
FAK phosphorylation, whereas the total FAK remained
unchanged. FAK phosphorylation follows RhoA and Cdc42
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Figure 1: DPPH scavenging activity, NO scavenging activity, andmetal chelation activity of TFW: (a) DPPH scavenging activity of TFW, gallic
acid, and chebulic acid; values are expressed as mean ± standard deviation; 𝑛 = 5. (b) Chelating activity of TFW, gallic acid, and chebulic acid;
values are expressed as mean ± SD, 𝑛 = 5. (c) Effect of TFW, gallic acid, and chebulic acid on serum lipid peroxidation; values are expressed
as mean ± SD; 𝑛 = 5.
activation, which promotes cytoskeletal remodeling leading
to the formation of stress fibers and filopodia [9]. As shown
in Figures 4(c), 4(e)-4(f), TFW significantly inhibited RhoA
and Cdc42 expression.
3.6. TFW Inhibits VSMC Proliferation. PDGF-BB, a chemo-
tactic and mitogenic factor, gets upregulated in atherosclero-
sis and restenosis [2]. As shown in Figure 5(a), stimulation
of VSMCs with PDGF-BB increased the cell number after
24 h. The treatment of TFW dose dependently inhibited
VSMC proliferation induced by PDGF-BB. TFW at con-
centrations of 50, 100, and 250𝜇g/mL significantly reduced
the proliferation rate to 81.6%, 72.3%, and 64% of the control
(PDGF-BB treated without TFW). To confirm that the
inhibitory effects were not due to toxicity or damage to the
cells, various concentrations of TFWwere treated in nonstim-
ulated cells for 24 h. TFW had no effect on the basal level of
cell viability. However, TFW at a concentration of 500𝜇g/mL
possessed cytotoxicity (Figure 5(b)). So, this concentration
was not included in further studies.
3.7. TFW Inhibits MAPK Signaling to Suppress VSMC Pro-
liferation. MAPKs, which have different functions and can
crosstalk at several levels to initiate the transcription of
several immediate early genes required for proliferation,
are activated in response to inflammatory and atherogenic






























































































































































Figure 2: NO production, iNOS, and COX-2 expression in LPS stimulated RAW 264.7. RAW 264.7 cells were pretreated with TFW for
1 h followed by stimulation with LPS for additional 24 h. (a) The cell viability was determined using MTT assay. (b) NO production was
measured using Griess reagent. (c)The expression of iNOS and COX-2 was determined byWestern blot. 𝛽-actin was used for normalization.
(d) Normalized quantitative data for iNOS expression. (e) Normalized quantitative data for COX-2 expression. Values are expressed as mean
± SD; 𝑛 = 4. ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01 versus control (LPS alone).
stimuli including PDGF-BB [4]. Serum deprived VSMCs
were stimulated with PDGF-BB for 15min and the activation
of ERK1/2 and JNK was determined by Western blot. As
shown in Figure 5(c), stimulation with PDGF-BB overex-
pressed pERK1/2 and p-JNK. The pretreatment of TFW
inhibited ERK1/2 and JNK phosphorylation.
4. Discussion
In this study, we showed that TFW possesses strong anti-
oxidative activity. Also, TFW inhibited proinflammatory
mediators, iNOS and COX-2 expression in RAW267.4 cells.
Furthermore, TFW attenuated PDGF-BB induced VSMC
proliferation and migration. Oxidative stress plays an impor-
tant role in the progression of atherosclerosis. The reactive
oxygen and nitrogen species produced by vascular cells
contributes to endothelial dysfunction and plaque disrup-
tion [26]. ROS can activate a complex cascade of sig-
nal transduction pathways that are highly associated with
inflammation, immunity, and atherosclerosis [27]. TFW
possessed strong DPPH scavenging activity with the pos-
sibility to act as primary antioxidants. Lipid peroxidation
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Figure 3: Effect of TFW on VSMC migration. (a) Subconfluent VSMCs were scraped off with a pipette tip to induce wounds and then the
cells were treated with TFW for 1 h followed by PDGF-BB treatment. Images of wounded area were captured immediately (time 0) and 6, 12,
and 24 h after injury. (b) Finally wound closure was quantified as percentage of the initial wound area that had been recovered with VSMCs.
Values are expressed as mean ± SD (𝑛 = 5). ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01 versus control (PDGF-BB alone); original magnification 200x. (c) The
cells were allowed to migrate in the presence of PDGF-BB and the indicated concentrations of TFW for 6 h. After staining with eosin and
hematoxylin, the migrated cells were counted (d) in 5 high power fields (200x). Values are expressed as mean ± SD (𝑛 = 5). ∗𝑃 < 0.05 and
∗∗
𝑃 < 0.01 versus control (PDGF-BB alone).
is catalyzed by metal ions to alkoxy and peroxy radicals
and TFW strongly inhibited metal-induced serum lipid
peroxidation. Moreover, TFW possessed strong iron-binding
capacity, suggesting that its inhibitory role in serum lipid
peroxidation might be due to its chelating effect. Sun et
al. reported that chebulic acid efficiently scavenged free
radical and significantly reduced the tert-butyl hydroper-
oxide- (t-BHP-) induced cell cytotoxicity and intracellular
ROS in rat hepatocytes [28]. The strong metal-chelating
activity of TFWmight be due to higher tannins content in it as
they possess more structural features for complexing metal
ions [29]. Several recent studies demonstrated the therapeutic
benefits of chelators in metal-catalyzed oxidative stress-
mediated chronic diseases including diabetes and cardiovas-
cular diseases [30].
Inflammation has been considered as the primary process
of atherosclerosis [11, 12]. We determined iNOS and COX-2
expression andNOproduction in LPS stimulated RAW264.7
cells as biomarkers of inflammatory response.The circulating
monocytes get recruited and differentiated into macrophages
in response to monocyte chemoattractant protein (MCP-1)
[10]. Lee et al. reported that chebulic acid rich T. chebula
inhibited monocyte adhesion to endothelial cells by inhibit-
ing ICAM-1 expression suggesting a potential role of TFW
in inhibiting circulating monocytes recruitment into the
intima [31]. It is interesting that a significant correlation has
been found between the degree of macrophage infiltration
and endothelial ICAM-1 expression in atherosclerotic lesions
[32]. Activation of macrophages in the intima results in iNOS
andCOX-2 synthesis. NO production due to catalytic activity









































































































































































Figure 4: Effect of TFW on MMP-2 and MMP-9 expression. VSMCs were pretreated with TFW for 1 h followed by stimulation with TNF-𝛼
for 24 h. (a)The proteolytic activity of MMP-2 andMMP-9 in conditioned medium and cell lysate was measured by gelatin zymography.The
protein expression of MMP-9 was determined by Western blot. GAPDH was used for normalization. (b) Normalized quantitative data for
MMP-9 protein expression. (c) Serum starved VSMCs were pretreated with indicated concentrations of TFW for 1 h followed by stimulation
with PDGF-BB for additional 15min. The cell lysates were assayed for protein expression of pFAK, FAK, RhoA, and Cdc42. (d) Normalized
quantitative data for FAK activation. (e) Normalized quantitative data for Cdc42 expression. (f) Normalized quantitative data for RhoA
expression. Values are expressed as mean ± SD; 𝑛 = 3. ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01 versus control (PDGF-BB alone).













































































Figure 5: Effect of TFWon PDGF-BB induced VSMC proliferation. (a) Serum starved VSMCs were pretreated with indicated concentrations
of TFW followed by stimulation with PDGF-BB (20 ng/mL) for 24 h. Cell proliferation was measured byMTT assay and values are expressed
as mean ± SD; 𝑛 = 6. ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01 versus control (PDGF-BB alone). (b) Serum starved VSMCs were treated with indicated
concentrations of TFW without stimulation for 24 h. Cell viability was measured by MTT assay. (c) Serum starved VSMCs were pretreated
with indicated concentrations of TFW for 1 h followed by stimulation with PDGF-BB for additional 15min. The cell lysates were assayed for
protein expression of p-ERK1/2, ERK1/2, pJNK, and JNK. Values are expressed as mean ± SD; 𝑛 = 6. ∗𝑃 < 0.05 versus normal (untreated).
of iNOS results in subsequent formation of peroxynitrite that
can lead to LDL oxidation [12, 13]. Also, excessive COX-
2 expression plays a key role in inflammatory disorders
including atherosclerosis and inhibition of COX-2 expression
is a therapeutic target for inflammatory diseases [11]. TFW
inhibited iNOS and COX-2 expression and NO production,
suggesting their beneficial role in the management of inflam-
mation.
Since VSMC proliferation and migration are one of the
leading factors in the progression of atherosclerosis and
restenosis [3], inhibition of VSMC proliferation and migra-
tion represents an important therapeutic strategy for the
prevention of atherosclerosis and restenosis. Various growth
factors, including PDGF-BB and TNF-𝛼, are upregulated
in atherosclerosis [1, 2]. In our in vitro model of VSMC
proliferation, the treatment of TFW dose dependently inhib-
ited PDGF-BB induced VSMC proliferation. The molecu-
lar mechanisms that regulate PDGF-BB-mediated responses
have been intensively studied in recent years. PDGF-BB
activate MAPKs known as JNK, P38, and ERK, which can
crosstalk at several levels to initiate the transcription of
several immediate early genes involved in cell cycle that drive
cellular proliferation and growth in mammalian cells [4].
Our study showed that treatment of TFW strongly inhib-
ited PDGF-BB-induced ERK1/2 and JNK phosphorylation.
Chebulagic acid from T. chebula resulted in cell cycle arrest
by increasing the expression of cell cycle dependent kinase
(CDK) inhibitor p27 in retinoblastoma cells [33]. Moreover,
ERK/2 inhibitor caused cell cycle arrest to prevent VSMC
proliferation by inhibiting cyclins and CDKs expression [24].
Altogether, the inhibitory effect of TFW on VSMC prolifera-
tion could be due to cell cycle arrest via inhibition of ERK1/2
activation. VSMC migration would require, at a minimum,
(a) a chemoattractant to direct their movement toward the
intima, (b) the ability to breach and transverse the ECM bar-
riers, and (c) the activation of the cellular machinery for cell
movement in response to the chemoattractant [34]. We used
PDGF-BB as a chemoattractant, since considerable evidence
supports a role of PDGF-BB in VSMCmigration in vitro and
in vivo [5]. TFW strongly inhibited PDGF-BB inducedVSMC
migration. The second requirement for VSMC migration is
to degrade ECM, which is mediated by MMPs [6]. The basal
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level of MMP-9 in VSMCs is low and its expression can be
induced by TNF-𝛼 [20, 22]. TFW markedly decreased TNF-
𝛼 induced MMP-9 enzymatic action and protein expression
while MMP-2 was constitutively secreted. To explore the
possible underlying MMP-9 inhibitory mechanism of TFW,
we attempted to examine the effect of TFW in JNK activation.
It has been well reported that the phosphorylation of tran-
scription factor c-Jun by JNK results in translocation of the
Fos-Jun complex to the nucleus and activation of MMP-9
promoter [35]. We previously showed that ERK inhibitor
weakly and JNK inhibitor strongly inhibited the enzymatic
action and protein expression of MMP-9 [8]. We found that
TFW inhibited JNK activation, which might in turn inhibit
MMP-9 expression to inhibit VSMC migration. Another
possible reason for inhibition of enzymatic action of MMP-
9 is chelation of Zn+2 in the catalytic site of MMPs by TFW,
thereby causing inactive protease. The third requirement for
VSMC migration is cytoskeleton remodeling mediated by
ECM or PDGF-BB, which drives the cellular machinery
through FAK activation. Activated FAK has the ability to
transduce signals downstream by interacting with multiple
signaling molecules, including small GTPases [36]. The Rho
GTPases including RhoA and Cdc42 are involved in medi-
ating cytoplasmic actin filament organization that occurs
in migrating cells stimulated by chemoattractants [37, 38].
TFW inhibited PDGF-BB induced FAK phosphorylation and
subsequent small GTPases, RhoA and Cdc42, expression
to inhibit cytoskeleton remodeling. These findings strongly
suggest that TFW is a potent inhibitor of VSMC migration.
5. Conclusions
In conclusion, we demonstrated that TFW scavenged oxi-
dation and inhibited the production of proinflammatory
mediators in LPS stimulated RAW 264.7 cells. Similarly,
TFW attenuated PDGF-BB induced VSMC proliferation and
migration.The anti-proliferative effect of TFWappeared to be
dependent on inhibition of ERK1/2 activation. Similarly, the
antimigratory effect of TFW is found to be dependent on its
inhibitory action on MMP-9 expression and FAK activation.
Based on our current findings, we speculate that TFW could
be used as a therapeutic agent in the prevention of atheroscle-
rosis. However, further studies are needed to identify the
possible active compounds that are possibly responsible for
the antiatherosclerotic properties of TFW,whichmay provide
an opportunity to develop a new class of antiatherosclerotic
drugs.
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